NEW YORK (GenomeWeb News) – The Fox Chase Cancer Center in Philadelphia has launched the Institute for Personalized Medicine, which will use the center's sample repository and oncology programs along with sequencing to develop personalized chemotherapy approaches.

The IPM will use the center's biosample repository and tumor bank to develop genetic information about individual tumors, and it will incorporate this type of data in its Phase I Clinical Trials Program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.